Introduction
Cri tically ill patients often experience stress-induced hyperglycemia and high levels of insulin resistance, even with no prior diabetes. [1] [2] [3] [4] [5] [6] [7] Hyperglycemia worsens outcomes, increasing the risk of severe infection, 8 myocardial infarction, 1 and critical illness such as polyneuropathy and multiple organ failure. 7 The occurrence of hyperglycemia, particularly severe hyperglycemia, is associated with increased morbidity and mortality in this group of patients. 1, 3 Some studies have shown that tight glucose control (TGC) reduced intensive care unit (ICU) patient mortality by 45% following control limits of 110 to 140 mg/dl. 7, [9] [10] [11] However, there is a little agreement on what constitutes desirable glycemic performance, [12] [13] [14] particularly with regard to how TGC affects outcome. Thus, despite the potential, many ICUs do not used fixed protocols. 4, 12, 13, 15, 16 Overall, any glycemic control protocol must reduce elevated blood glucose (BG) levels with minimal hypoglycemia, thus minimizing risk in the presence of significant variability in insulin resistance resulting from conflicting drug therapies and dynamically evolving physiological condition, among others. As the patient condition evolves, particularly acutely, TGC and intensive insulin therapy can prove difficult. Protocols or clinical practices that utilize large insulin doses can thus suffer from high glycemic variability and excessive hypoglycemia. 17 As a result, several clinical trials have not achieved the benefit of TGC. [17] [18] [19] [20] Hence, there is significant difficulty in providing protocols that simultaneously provide good performance and TGC without excessive hypoglycemia. The two major reasons or causes of hypoglycemia are often reported to be clinical error and, or combined with, infrequent measurement using bedside glucometers or blood gas analyzers. 19, [21] [22] [23] [24] Thus, the use of continuous glucose monitors (CGMs) with their rapid 2-to 5-minute measurement rates offers the opportunity to better monitor patients so that hypoglycemia could be avoided, mitigating this risk significantly.
Typically, in most ICU studies, blood glucose is measured every one to four hours, faster only if the levels are already hypoglycemic. The result can be very variable glycemic control, especially with longer measurement intervals. 25 Thus, CGMs would also provide the potential to control glycemic levels better or more tightly, minimizing variability, which has also been strongly linked with mortality, independent of glycemic levels, in these cohorts. 26, 27 Abstract cont.
Results:
The median filter reduced MAPE from 17.4% [standard deviation (SD) 13%] to 9.3% (SD 7%) over the cohort. For the integral-based alarm, median per-patient detection times ranged, t, from -35 minutes (before event) to -170 minutes, with zero to two false alarms per patient over the cohort and different alarm parameters. For a simple glycemic threshold alarm (three consecutive values below threshold), median per-patient alarm times were -10 to -75 minutes and false alarms were zero to seven; however, in one case, five of seven subjects never alarmed at all, despite the hypoglycemic event.
Conclusions:
A retrospective study used clinical hypoglycemic events from a TGC study to develop and analyze an integralbased hypoglycemia alarm for use in critical care TGC studies. The integral-based approach was accurate, provided significant lead time before a hypoglycemic event, alarmed at higher glycemic levels, was robust to sensor noise, and had minimal false alarms. The approach is readily generalizable to similar scenarios, and results would justify a pilot clinical trial to verify this study.
This research used a single-Gaussian noise model. The model was derived to produce similar errors on a similar cohort to those reported by Goldberg et al. 28 in a 2004 study of the Medtronic continuous glucose monitoring system (MiniMed Medtronic, Northridge, CA) in a medical ICU. In the study by Goldberg and associates, 28 calibration of the CGM sensors was performed retrospectively with all available data and at least four reference BG measurements per day, removing any bias. This report was used as it was critical care specific and reported a wide range of error statistics versus a reference measure. Goldberg and colleagues 28 reported errors for measurements in five BG ranges. The noise model was thus created to match the reported noise statistics over the same five ranges.
More specifically, it is a Gaussian distributed random error with a mean absolute percentage error (MAPE) of 12.8% and a standard deviation (SD) of 10% on a cohort similar to Goldberg's. However, the percentage error was greater for lower blood glucose levels here (MAPE 17.8%) given the relatively constant mean absolute difference in milligrams per deciliter seen. Because such lower measurements are encountered more frequently in this study involving tightly controlled patients on SPRINT, which are limited to the time periods around hypoglycemic episodes, the errors in MAPE are conservatively higher. However, these errors are also more relevant as they are specific to the hypoglycemia alarm situation studied here.
However, there have been relatively few successful investigations of CGMs in critical care use, 28 although they are well studied in type 1 diabetes. 29, 30 In particular, one set of TGC trials that used them was not particularly successful. 31, 32 They offer the trade-off of sometimes significant added sensor noise with their far higher, automated sampling rate. 28, 33 However, because these sensors and their algorithms are improving every year, the technology is in a state of constant evolution. Hence, their eventual effective use is potentially inevitable and will free clinicians to provide tighter control in the face of highly dynamic metabolic behavior.
This article used data from the Specialized Relative Insulin Nutrition Titration (SPRINT) TGC study. 11 It examined each of the seven cases of hypoglycemia that was not a function of sensor error. Conservative sensor noise based on reported data in the literature was added to model results fitted to data to simulate the use of CGM. A novel integral-based algorithm with a median filter was used to develop a robust and readily generalized alarm approach and to prove the concept in this in silico study.
Subjects and Methods

Subjects
This research was conducted as a retrospective study using records from seven patients admitted to the Christchurch Hospital ICU between 2005 and 2007. Patients were included if they had one or more severe hypoglycemic episodes (BG <40 mg/dl) while on the SPRINT glycemic control protocol. 11 Patients were excluded if the hypoglycemic episode appeared to be due to sensor failure 34 or to a recording error. Details of the cohort are shown in Table 1 .
The requirement for patients in this study to be on the SPRINT protocol ensured that they had regular, consistent, and accurate records of blood glucose levels (every one to two hours) and insulin and nutrition administration. 11 The use of these patient records fell under existing ethics approval granted by the Upper South Regional Ethics Committee, New Zealand.
Continuous Glucose Monitor Noise Model.
Continuous glucose monitor sensor error consisted of a bias due to calibration drift with a random or quasi-random noise superimposed on top. Calibration drift due to sensor degradation over time was not considered in this study, as this is controlled by the specific calibration protocol used with the sensor. The random component of noise In Silico CGM Measurements. Using a model derived from the clinically validated glucose-insulin model of Lin and colleagues 35 and hospital records, a blood glucose profile was generated for each patient at 5-minute intervals based on their model-fitted, time-varying insulin sensitivity. These profiles were generated in a data window starting 9 hours before the severe hypoglycemic event at a normoglycemic level and ending 4 hours after an actual measured hypoglycemic event. Random noise was added to this "actual" blood glucose profile using the single-Gaussian model, creating a sequence of virtual CGM sensor outputs.
Continuous Glucose Monitor Filtering. To simulate the real-time use of a CGM device, an algorithm was implemented in MATLAB ™ (MathWorks, Natick, MA) to step through the sequence of virtual CGM readings and filter them without knowledge of "future" values, as would be the case clinically. Thus, the clinical situation can be simulated for developing an alarm methodology.
A combination median filter and least mean squares (LMS) curve fit was used to smooth the noisy virtual CGM sequence. Initially, a weighted median filter was applied to the prior 30 minutes of noisy data, followed by a linear least squares fit over previous hour median-filtered data.
The fundamental steps to implement the median filter at any given time, t = x, are 1. Take current and two prior CGM readings (three samples, 10-minute window) and find median value This set of steps is based on well-known median filtering 36 and LMS polynomial fitting methods.
Multiple windows give an empirically designed tradeoff between fast dynamics and response, and longer windows and smoother filtered outputs with lag. 37 This approach is also less computationally expensive than integral-based approaches or Kalman filtering. [38] [39] [40] Alarm Design. An algorithm was required to trigger an alarm when the filtered blood glucose sequence appeared to be heading toward a hypoglycemic event. While better than raw data, filtered data were still too noisy to apply a simple set of conditions such as m measurements below a threshold BG value. Therefore, a windowed integral method [essentially a finite impulse response (FIR) filter 41 ] was implemented using filtered data. This approach is both simple and robust to noise.
Specifically, the area between the BG curve and a specified level was calculated within a window of prior samples. When this integral became less than a preselected threshold value, an alarm was triggered, indicating an impending hypoglycemic episode. Several combinations of these parameter values were simulated. Figure 1 shows an example. An alarm was considered false if the following conditions held:
• There was more than one alarm for each actual hypoglycemic episode per patient and • For two clinical blood glucose measurements either side of the alarm, no value was less than or equal to 40 mg/dl.
It should be noted that this use of prior knowledge of clinical BG measurements was only used after filtering and processing to identify any false alarms and would thus not be part of a real-time implementation.
Analysis. For analysis, the timing of this alarm was compared with the time that the episode was actually detected in the hospital. This value essentially measures the lead time to intervene and the minimization of minor or moderate hypoglycemia. The number of false alarms was also recorded to ensure that the method was accurate.
To get meaningful results with random noise, this study used a Monte Carlo analysis approach. Each patient's model-based, true BG profile was passed through the single-Gaussian random noise generator 100 times, creating 100 different virtual CGM sequences per patient. Results of these 700 trials with the filter and alarm algorithm were analyzed using nonparametric statistics to determine overall cohort and per-patient results.
Results were reported in terms of alarm lead time and number of false alarms for several analyses and thresholds. A simple glycemic threshold method is also shown for comparison.
Results
Filter Results
Median and LMS-based filter design resulted in a significant noise reduction. Specifically, the MAPE on raw noisy virtual outputs was reduced from 17.4% (SD 13%) to 9.3% (SD 7%) over the cohort. However, given relatively smaller numbers of hours (N = 91 hours over seven patients), the distributions were not perfectly normal. Thus, the nonparametric filtering output was a reduction from a median absolute percent error (APE) of 14.4% [interquartile range (IQR): 6.8-24.9] to a median APE of 7.6% (IQR: 3.6-13.2). Mean absolute differences were 14.7 and 7.7 mg/dl, respectively. All these values compare well with results reported in the literature. 28, 39, 40 
Alarm Analysis Results
The primary result for this study was the time difference between an alarm triggered by simulated CGM data and when a hypoglycemic episode was detected by actual measurement. As a secondary result, the number of false alarms triggered was also reported as a measure of the reliability of the alarm algorithm. Table 2 shows results for the integral-based alarm for different window lengths and trigger threshold values. Negative time values indicate that an alarm was triggered before a hypoglycemic event was measured. These results were counted over all 700 Monte Carlo simulation runs.
Despite sensor noise, there was a clear improvement in the time of detection of hypoglycemic episodes using CGM sensors compared to standard clinical procedures measuring one to two hourly with, in this case, SPRINT.
The degree of improvement depends on the design and parameters of the alarm algorithm presented. The reliability of the alarm, as measured by the number of false alarms, decreases with increasing advanced detection time.
As a comparison, Table 3 shows results of using a simple glycemic level alarm algorithm. The alarm was triggered in this case by three consecutive CGM readings below the threshold BG value and a negative average gradient over those three points. It is obvious that the performance is significantly worse than the integral-based algorithm. False alarm values of -1 indicate that no alarms were triggered at all, despite the hypoglycemic event occurring in each case. Thus, results in Table 3 show that for more than 75% of the time, with a threshold value of 50 mg/dl, no alarm was triggered despite the oncoming, glycemically near, hypoglycemic event. Second, the range of hypoglycemia detection is still well in advance of the measured hypoglycemic event at 15 hours. The hypoglycemic value is 39 mg/dl and thus it may also be assumed that it likely occurred very near this time. The IQR of detection is 50-120 minutes before the event, which was preceded by a stable range of glycemia around 90 mg/dl for several hours. 
Discussion
While CGMs are well studied in ambulatory type 1 diabetes patients, 29, 30 there have been relatively few successful investigations of CGMs in critically ill inpatients. 28 There are several important differences between critically ill patients and ambulatory type 1 diabetes patients, which may have an impact on the performance of the CGM device. Critically ill patients are generally insulin resistant 1-7 due to high levels of counterregulatory stress hormones and consequently hyperglycemic without adequate control. Insulin resistance, coupled with continuous feeding and sedation, limits the rate of change of blood glucose levels, preventing rapid changes that can occur with meals and exercise, possibly resulting in improved CGM performance compared to ambulatory individuals. However, peripheral edema, a lack of dynamic circulation of interstitial fluid due to a nonambulatory state, 42 may reduce performance. 
Performance
Results of this study showed that using CGM sensors for early hypoglycemic event detection in an ICU can be very effective. Depending on the design of the filter and alarm algorithm, reliably detecting hypoglycemic events 1-2 hours before they would normally have been picked up is quite feasible, allowing very early intervention. Early detection and intervention may reduce or eliminate both the events themselves and thus any harm caused by these episodes.
Filtering the raw CGM output with the median filter/LMS fit provides better results than using a more common FIR filter (results not shown). Raw, noisy CGM data had a MAPE of 17.4%-the median/LMS filter reduced this to 9.3% for this cohort. To provide a comparison with "standard" filtering methods, a ninth-order, low-pass FIR filter designed using the window method resulted in a MAPE of 13.7%, which is much higher than this filtering approach for the same data.
Using an integration-based algorithm to trigger the alarm is much more effective than a simple consecutive valuebased or derivative-based method. The residual postfiltering noise is still enough to trigger multiple false alarms with a high threshold or to prevent any alarms at all with a lower threshold when simply using filtered BG values to trigger the alarm. Table 3 illustrated this point, particularly with an alarm threshold of 60 mg/dl. No alarms were triggered in more than 50% of the simulations with this threshold value, but in 25% of simulations there were six or more false alarms triggered, as the IQR 75th percentile is 6 in Table 3 for some cases.
Derivative-based algorithms were not considered in this study as they are known to be highly susceptible to noise, whereas integrals filter noise much like a basic FIR or other digital filter. The integral-based algorithm is thus more robust to noise and therefore provides a much more reliable alarm.
Sensor error due to bias has not been modeled in this research, as it is a calibration issue rather than strictly noise. However, if present and positive (BG actually lower than measured), bias would reduce the lead time for hypoglycemic detection. If negative bias was present (BG actually higher than measured), the detection lead time would be improved; however, the number of false positive detections may also increase. The potential presence of sensor bias therefore necessitates careful calibration of the device and tuning of the detection algorithm to ensure good performance.
Tuning the integral algorithm to optimize the performance involves adjusting the window length and the alarm threshold parameters. There is a trade-off with integral window length, where long windows provide a more reliable alarm, but with less advance warning than shorter windows. With a long window, the integral takes longer to fall below the threshold once the blood glucose starts dropping. This trade-off also explains why a lower alarm threshold parameter is more reliable, but provides less warning than a higher value.
Selecting optimal values for window length and alarm threshold would ideally be done over a larger set of patients than used in this proof of concept analysis. This study has a number of limitations; however, the method presented can be readily generalized to ICU populations. This performance would justify a pilot clinical trial, not only to validate the detection algorithm, but also the assumptions behind the simulated noise.
Limitations
Clinical. The small number of patients in this study (seven) may mean that the results are not representative of the overall population behavior. Repeating the study with a larger cohort would provide a more statistically powerful result. However, in the Christchurch ICU, all patients receiving insulin are on the SPRINT glycemic control protocol and therefore very unlikely to suffer a serious hypoglycemic event (~4% of patients or less), making it difficult to recruit a large cohort. Data from a different study might alleviate this issue for in silico studies or a pilot clinical trial should be developed.
A further limitation is that only hypoglycemic episodes at or below 40 mg/dl were investigated in this research. The SPRINT protocol controls patients between 72 and 108 mg/dl 11, 25 without significant prejudice toward lower values in this range. Hence, examining a higher hypoglycemic level (e.g., moderate hypoglycemia <60 mg/dl) is infeasible, as getting closer to the target band results in more false alarms. Uncontrolled or poorly controlled patients may permit the investigation of CGM hypoglycemic detection performance on less severe episodes.
Finally, although the virtual patient simulation method is clinically well validated, 25, 34, [43] [44] [45] this in silico study needs to be confirmed with clinical testing. The actual blood glucose sequences used were model based, derived from one to two hourly clinical measurements with added noise, not real CGM output data. Testing and Signal Processing. Signal processing and noise model limitations of this study were that we only considered a conservative noise model and simple filtering methods and ignored calibration drift or bias. We assumed nonbiased, random-independent noise based on reported data.
Continuous glucose monitor sensor error consisted of a bias due to calibration drift with random or quasirandom noise superimposed on top. Calibration drift due to sensor degradation over time was not considered in this study. Without correction, calibration drift will show up as though the actual BG measurements were higher or lower in a relatively consistent manner as the sensor gain drifts. 40 This drift would cause the alarm to trigger early (possibly falsely) or late. However, such calibration drift is very much a function of the frequency and quality of calibration measurements, which can likely be controlled more readily in a critical care setting.
The random component of noise modeled in this study was assumed to be independent and normally distributed.
The assumption of independent errors may not model the actual CGM sensor noise perfectly, but with no reported time-series data available in the literature (to the authors' knowledge), a more comprehensive model was not possible.
The Gaussian noise model employed was conservative (MAPE = 17.4% for this cohort), as it was based on data from a 2004 study 28 and there have been significant advances in emerging CGM sensor hardware and software since that time. Improved sensor noise characteristics, combined with more advanced filtering techniques, would result in a much cleaner CGM data stream and hence more reliable alarms. However, the higher noise levels used thus provide a conservative test of the approach.
This study only investigated simple median/LMS and FIR filters. More advanced filtering techniques, such as adaptive filtering and Kalman filtering, have been shown to produce very good results. 39, 40 Kalman filtering can also be used to correct for calibration drift, 40 which was not studied in this case. However, it is difficult to compare performance here as all studies have used different data with different noise or error distributions from the sensors.
Analysis Method. It should be noted that this proof of concept study examined only hypoglycemic events.
Thus, there were no opportunities to examine "false positive" alarms. The false alarms here occurred significantly before or, in some cases, after the hypoglycemic event.
The false alarms here are thus more representative of a lack of robustness.
However, as seen in Figure 3 , moderate hypoglycemia, which is corrected before the severe hypoglycemic event, can still trigger a false alarm if the thresholds are not optimized perfectly-an effort that may be nearly impossible given the variety of patient behaviors that can be encountered. That said, a trigger at this level is still clinically useful and definitely not spurious with regard to treating. Thus, another view of Figure 3 would be that these false alarms, if not frequent, may be earlier precursors of hypoglycemic dynamics in the patient's response to the intervention, which could potentially be used to moderate care.
Summary. Finally, while these are significant limitations, this article focused on proof of concept for a novel integration-based method of hypoglycemia detection. The primary goal was to develop a method for accurate, reliable alarms with good warning that account for realistic or greater sensor noise that was also readily generalizable to similar sensors. Thus, the larger noise used is a conservative test, and application to cases with lesser noise will provide better results. The main comparison to other alarm methods should then be in terms of relative performance presented here. Overall, the good result with suboptimal filtering and a conservative noise model only serves to show that the method is feasible and deserves further investigation.
Finally, examining the SPRINT and prior pilot trial results, hypoglycemia could have been avoided without using CGM if measurements were made every 30 minutes (48/day). However, this rate potentially is invasive to the patient and far too burdensome for regular practice in a clinical ICU environment. Hence, CGM offers the opportunity to observe trends semi-invasively and to reduce clinical burden, while also increasing potential safety by mitigating the trade-off between the burden of more frequent measurement and the safety and TGC outcomes that it can provide. In SPRINT, even one to two hourly measurements yielded only 10 events over eight patients (2%), a majority of which were due to clinical errors. As a result, the methods presented here are thus about reducing a potentially small number of events to zero, as well as mitigating the clinical burden of frequent measurement.
